18F-FDG PET/CT and Survival Prediction for PD-1 Inhibitor–Treated Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma Under PD-1 Inhibitors
Cancers (Basel) 2021 Mar 01;[EPub Ahead of Print], C Sachpekidis, JC Hassel, A Kopp-Schneider, U Haberkorn, A Dimitrakopoulou-StraussFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.